SA’s competition watchdog has dropped its case against global pharmaceutical giant Johnson & Johnson (J&J) over the high price of lifesaving tuberculosis (TB) drug bedaquiline.
Bedaquiline, which is sold under the trade name Sirturo, is used to treat drug-resistant TB. SA has one of the highest rates of TB in the world.
The Competition Commission launched an investigation into J&J and its subsidiary Janssen Pharmaceutica in September last year.
South Africans need to be in the know if we want to create a prosperous future. News24 has kept the country informed for 25 years, and we’re about to enter a new chapter of fearless journalism. Join our free subscription trial to unlock this story and a world of news aimed to inform, empower, and inspire.
